Varicella Vaccination With Pulmicort

• Status: Completed
• Trial end date: 2003-10-01
• Target enrollment: 0
• Participant gender: All

Summary

A study to determine whether treatment with Pulmicort in children has any effect on the varicella vaccine

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AstraZeneca
• Treatments: Budesonide

Criteria

Inclusion Criteria:

• Children between the age of 10 months and 8 years,

• have asthma or shown recent signs suggesting asthma,

• have a parent or guardian willing to comply with study requirements

Exclusion Criteria:

• Varicella zoster immune globulin (VZIG) within 5 months prior to immunization,

• Previous varicella immunization,

• an immunization or allergy immunotherapy 4 weeks prior to immunization,

• Severe asthma,

• have another persistent lung disease,

• have a planned hospitalization for the duration of study